PharmAlliance (Waud Capital Portfolio) Acquires CHEORS
April 16, 2024
PharmAlliance, a pharmaceutical and life sciences services platform and portfolio company of Waud Capital Partners, has acquired Complete Health Economics Outcomes Research Solutions (CHEORS). The deal expands PharmAlliance's HEOR, RWE, and market access capabilities and marks the platform's third strategic acquisition as it broadens its global launch and commercialization services.
- Buyers
- PharmAlliance, Waud Capital Partners
- Targets
- Complete Health Economics Outcomes Research Solutions (CHEORS)
- Platforms
- PharmAlliance
- Industry
- Healthcare Services
- Location
- North Carolina, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
ADVI Health Acquires Partnership for Health Analytic Research (PHAR)
August 23, 2024
Healthcare Services
ADVI Health has acquired Partnership for Health Analytic Research (PHAR), a global HTA and HEOR consultancy with roughly 20 years of experience delivering real-world evidence, patient registries, and value strategy research for biopharma clients. The acquisition expands ADVI’s Strategic Analytics, Value and Economics (SAVEs) capabilities—bringing PHAR’s HEOR and implementation science expertise into ADVI’s market access and commercialization services.
-
GHO Capital Acquires Genesis Research
November 16, 2021
Healthcare Services
London-based GHO Capital Partners has acquired Genesis Research, a Hoboken, New Jersey–headquartered provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) services. The transaction, which follows a prior recapitalization by Rallyday Partners, gives Genesis additional capital and European market expertise to pursue global expansion and adjacent capability growth.
-
EVERSANA Acquires Cornerstone Research Group
October 30, 2019
Healthcare Services
EVERSANA has agreed to acquire Canada-based Cornerstone Research Group, a health economics and outcomes research (HEOR) firm headquartered in Burlington, Ontario. The acquisition adds HEOR, economic modeling, evidence synthesis and market access capabilities to EVERSANA’s integrated commercial services platform to better support pharmaceutical and medical device clients globally.
-
Ampersand Capital Partners Invests in Alliance Pharma
November 18, 2021
Healthcare Services
Ampersand Capital Partners has made a growth equity investment in Alliance Pharma, a Malvern, Pennsylvania–based bioanalytical CRO. The funding will support Alliance’s expansion of global reach, scientific capabilities, and operational capacity while founder Frank Li remains a significant shareholder.
-
ATHAGORAS Group Acquires CSO Pharma Consulting GmbH
November 18, 2024
Healthcare Services
ATHAGORAS Group has acquired CSO Pharma Consulting GmbH to expand and internationalize its pharmacovigilance, medical affairs, quality management and GDP consulting capabilities across the pharma and healthcare sectors. The deal adds a specialized provider of PV and regulatory support to ATHAGORAS' life‑sciences services platform while CSO retains focus on organic growth and continuity for clients and employees.
-
Athagoras Acquires Quantify Research
January 8, 2025
Healthcare Services
Athagoras, a Munich-based life sciences consulting platform, has acquired Quantify Research, a Nordic-headquartered specialist in real-world evidence (RWE), health economics (HEOR) and market access. The acquisition expands Athagoras' RWE and market access capabilities and strengthens its presence in the Nordic region and Asia-Pacific to better serve global pharmaceutical clients.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.